Update
$Inventiva (IVA.US)$ Inventiva Gets New Funding for Late-stage Trial of Fatty Liver Disease TreatmentMT Newswires· 5 mins agoInventiva (IVA.PA) secured new financing primarily earmarked for the phase 3 trial of its lanifibranor treatment for metabolic dysfunction-associated steatohepatitis, a fatty liver disease and its subsequent marketing approval and commercialization.The clinical-stage biopharmaceutical company secured an immediate financing of 94.1 million euros worth of shares and prefunded warrants, with a potential to reach up to 348 million euros, subject to the fulfillment of certain conditions, according to a Monday release.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more6
Lnova : They got a lot of money too it seems ?
Lnova : Inventiva secures financing of up to €348M to advance the Nativ3 phase 3 MASH study" data-render="ssr
Trytosaveabit OP Lnova : Yup!
Trytosaveabit OP Lnova : Thank you
Lnova Trytosaveabit OP : thank you
J L 7 2 : Just this post? Can't see the price at that time.
Trytosaveabit OP J L 7 2 : You need to adjust your chart settings to show full market Pre and Post market price!
J L 7 2 Trytosaveabit OP : 好的 我尽快去试
Trytosaveabit OP J L 7 2 : Grrr! Sorry translation didn’t work!